Monday, August 3, 2026

Apple’s Next iPhone Might Be Slimmer But Your Wallet Won’t Be

Apple is considering price hikes for the iPhone 16 Pro series while exploring new features, avoiding tariff-related perceptions.

NVIDIA Dips 1.25%, But Intel’s 7% Rally Helps Semiconductor Index Close Higher

Despite a 1% drop in Nvidia, Intel surged over 7%, leading to a slight rise in the semiconductor index, closing at 5090.79 points.

Japan and South Korea Reaffirm Trilateral Coordination With U.S. on North Korea Following Summit

Japan and South Korea reaffirm cooperation on North Korea, supply chains, and security during a summit amid global instability.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

1 Person, 1 AI: Discover SNUH.AI’s Game-Changing Medical Assistant Platform

Seoul National University Hospital's SNUH.AI aims to empower healthcare professionals with AI assistants for improved efficiency and personalized care.

Moderna secures EU approval for combined influenza-COVID vaccine mCOMIRNATY

Moderna's mCOMIRNATY, a combined COVID-19 and influenza vaccine, gains European approval for adults 50+, enhancing its respiratory portfolio.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

South Korea’s ARPA-H Project Revolutionizes Elderly Mental Health Solutions

South Korea will officially enter 'super-aged society' by late 2024 or early 2025, raising concerns over elderly mental health issues.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

JW Life Science launches medical care brand “Dr. Claro”

JW Life Science launches "Dr. Claro," a medical care brand with five certified products for wound management and skin protection.

CG Bio’s EasyMade TI: The First Custom Titanium Implant Approved by FDA 510(k) – What It Means for Patients

CG Bio's EasyMade TI titanium implant receives FDA 510(k) approval, marking a milestone for customized implants in the U.S. market.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Breakthrough in neuroscience research…precision correction technology for microscope image distortion developed

KAIST's research team developed a software algorithm to correct microscope image distortions, enhancing biological observation without extra hardware.

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.